Evaluation of maternal serum folate, vitamin B12, and homocysteine levels andfactor V Leiden, factor II g.20210G>A, and MTHFR variations in prenatallydiagnosed neural tube defects.
暂无分享,去创建一个
E. Erdogdu | R. Arısoy | O. Demirci | A. Cetinkaya | H. Aydin | A. Karaman | H. Simsek | Bilge B Geçkinli
[1] Q. Ning,et al. Investigations of single nucleotide polymorphisms in folate pathway genes in Chinese families with neural tube defects , 2014, Journal of the Neurological Sciences.
[2] Jun Xie,et al. Interaction between maternal 5,10-methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene variants to increase the risk of fetal neural tube defects in a Shanxi Han population. , 2013, Chinese medical journal.
[3] Y. Li,et al. Homocysteine, folate, vitamin B12 and B6 in mothers of children with neural tube defects in Xinjiang, China , 2012, Acta paediatrica.
[4] M. R. Pepper,et al. B12 in fetal development. , 2011, Seminars in cell & developmental biology.
[5] H. Yaman,et al. Serum vitamin B12 and homocysteine levels in pregnant women with neural tube defect , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[6] I. Cetin,et al. Maternal and Fetal Thrombophilia in Intrauterine Growth Restriction in the Presence or Absence of Maternal Hypertensive Disease , 2010, Reproductive Sciences.
[7] A. Keshtkar,et al. Maternal Folate and Vitamin B12 Status and Neural Tube Defects in Northern Iran: A Case Control Study , 2010, Iranian journal of pediatrics.
[8] I. Cech,et al. Serological Differences in Folate/Vitamin B12 in Pregnancies Affected by Neural Tube Defects , 2010, Southern medical journal.
[9] Andrew J. Copp,et al. Genetics of human neural tube defects , 2009, Human molecular genetics.
[10] D. Watkins,et al. Vitamin B(12) and birth defects. , 2009, Molecular genetics and metabolism.
[11] M. Canfield,et al. Maternal serum homocysteine and risk for neural tube defects in a Texas-Mexico border population. , 2009, Birth defects research. Part A, Clinical and molecular teratology.
[12] Xue Gu,et al. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China , 2009, Public Health Nutrition.
[13] J. Troendle,et al. Maternal Vitamin B12 Status and Risk of Neural Tube Defects in a Population With High Neural Tube Defect Prevalence and No Folic Acid Fortification , 2009, Pediatrics.
[14] E. Schiff,et al. Factor V Leiden and Antiphospholipid Antibodies in Either Mothers or Infants Increase the Risk for Perinatal Arterial Ischemic Stroke , 2009, Stroke.
[15] E. Van Obberghen,et al. Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: A multicenter case–control study , 2008, American journal of medical genetics. Part A.
[16] N. Akar,et al. Thrombophilia‐associated gene mutations in women with pregnancies complicated by fetal neural tube defects , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[17] M. Thompson,et al. Vitamin B12 and the Risk of Neural Tube Defects in a Folic-Acid-Fortified Population , 2007, Epidemiology.
[18] Gary M. Shaw,et al. Neural tube defects and folate: case far from closed , 2006, Nature Reviews Neuroscience.
[19] G. Bennett,et al. Failure of homocysteine to induce neural tube defects in a mouse model. , 2006, Birth defects research. Part B, Developmental and reproductive toxicology.
[20] D. Reddihough,et al. Factor V Leiden mutation: a contributory factor for cerebral palsy? , 2005, Developmental medicine and child neurology.
[21] M. Alikaşifoğlu,et al. Analysis of MTHFR 1298A>C in addition to MTHFR 677C>T polymorphism as a risk factor for neural tube defects in the Turkish population. , 2005, The Turkish journal of pediatrics.
[22] S. Lynch. Non‐multifactorial neural tube defects , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.
[23] N. Greene,et al. Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos , 2003, Anatomy and Embryology.
[24] G. Wells,et al. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. , 2000, American journal of human genetics.
[25] M. Khoury,et al. Neural-tube defects. , 1999, The New England journal of medicine.
[26] D. Shields,et al. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. , 1999, American journal of human genetics.
[27] F. Gabreëls,et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.
[28] M. den Heyer,et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida , 1995, The Lancet.
[29] J. Mulinare,et al. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. , 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[30] H. El-Bassyouni,et al. Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients. , 2007, Clinical laboratory.
[31] A. Motulsky. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. , 1996, American journal of human genetics.